First trimester uric acid and adverse pregnancy outcomes.
BACKGROUND
The association of elevated serum uric acid with the development of hypertension is established outside of pregnancy. We investigated whether first trimester uric acid was associated with the development of the following: gestational hypertension or pre eclampsia, these outcomes stratified by presence of hyperuricemia at delivery since this denotes more severe disease, preterm birth, or small for gestational age (SGA).


METHODS
Uric acid was measured in 1,541 banked maternal plasma samples from a prior prospective cohort study that were collected at a mean gestational age of 9.0 (± 2.5) weeks. Polytomous regressions were performed and adjusted for parity and prepregnancy body mass index (BMI).


RESULTS
First trimester uric acid in the highest quartile (>3.56 mg/dl) compared to lowest three quartiles was associated with an increased risk of developing pre-eclampsia (adjusted odds ratio (OR) = 1.82; 95% confidence interval (CI), 1.03-3.21) but not gestational hypertension. In women with hypertensive disease complicated by hyperuricemia at delivery, high first trimester uric acid was associated with a 3.22-fold increased risk of hyperuricemic gestational hypertension (HU) and a 3.65-fold increased risk of hyperuricemic pre-eclampsia (HPU). High first trimester uric acid was not associated with gestational hypertension or pre-eclampsia without hyperuricemia (H or HP) at delivery, preterm birth, or SGA. In women who developed hypertensive disease, elevated uric acid at delivery was only partly explained by elevated uric acid in the first trimester (r(2) = 0.23).


CONCLUSIONS
First trimester elevated uric acid was associated with later pre-eclampsia and more strongly with pre-eclampsia and gestational hypertension with hyperuricemia.
Department of Obstetrics, Gynecology and Reproductive Services, University of Pittsburgh, Pittsburgh, PA, USA. laughonsk@mail.nih.gov
S Katherine
SK
Laughon
Janet
J
Catov
Robert W
RW
Powers
James M
JM
Roberts
Robin E
RE
Gandley
D000328:Adult; D005260:Female; D006801:Humans; D046110:Hypertension, Pregnancy-Induced / Q000209:etiology; D033461:Hyperuricemia / Q000150:complications*; D007231:Infant, Newborn; D007236:Infant, Small for Gestational Age; D011225:Pre-Eclampsia / Q000209:etiology; D011247:Pregnancy; D011256:Pregnancy Outcome; D011261:Pregnancy Trimester, First; D047928:Premature Birth / Q000209:etiology; D014527:Uric Acid / Q000097:blood*
D014527:Uric Acid
Am J Obstet Gynecol. 2006 Jan;194(1):160
16389026
Br J Obstet Gynaecol. 1984 Feb;91(2):128-32
6696858
J Am Soc Nephrol. 2005 Jul;16(7):1909-19
15843466
Am J Pathol. 2000 Jan;156(1):321-31
10623681
Placenta. 2008 Mar;29 Suppl A:S67-72
18093648
Am J Obstet Gynecol. 2009 Oct;201(4):402.e1-5
19788971
Hypertension. 2005 Dec;46(6):1263-9
16246973
Reprod Sci. 2009 May;16(5):468-78
19196876
Hypertension. 2006 Dec;48(6):1037-42
17060502
N Engl J Med. 2008 Oct 23;359(17):1811-21
18946066
Placenta. 2009 Feb;30(2):195-200
19058847
Hypertension. 2001 Nov;38(5):1101-6
11711505
Am J Physiol Cell Physiol. 2009 Aug;297(2):C440-50
19535510
Hypertension. 2007 Feb;49(2):298-303
17190877
Am J Obstet Gynecol. 2009 Dec;201(6):582.e1-6
19729142
J Hum Hypertens. 1999 Jan;13(1):13-21
9928747
Am J Obstet Gynecol. 1996 Nov;175(5):1365-70
8942516
Diabetes Res. 1989 Apr;10(4):159-64
2612111
J Perinat Med. 1997;25(4):347-52
9350605
Am J Obstet Gynecol. 1995 Feb;172(2 Pt 1):642-8
7856699